Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiko Murata

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinics in Laboratory Medicine|November 7, 2009
Respiratory syncytial virus vaccine developmentYoshihiko Murata
Current Opinion in Pulmonary Medicine|April 23, 2008
Respiratory syncytial virus infection in adultsYoshihiko Murata
JMM Case Reports|July 1, 2017
Peripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosisBarbara Grzegorczyk, Yoshihiko Murata
Antiviral Therapy|October 20, 2007
Respiratory syncytial virus infection in adultsYoshihiko Murata, Ann R Falsey
Vaccine|June 26, 2012
Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in miceYoshihiko Murata, Seana C Catherman
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 18, 2021
Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocciSatoshi Iwata, Hayato Koyama, Yoshihiko Murata
The Journal of Infectious Diseases|March 3, 2007
Pulmonary complications of interpandemic influenza A in hospitalized adultsYoshihiko Murata, Edward E Walsh, Ann R Falsey
Archives of Internal Medicine|January 24, 2007
Impact of rapid diagnosis on management of adults hospitalized with influenzaAnn R Falsey, Yoshihiko Murata, Edward E Walsh
Cancer Science|November 20, 2020
ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signalingZeinab Kosibaty, Yoshihiko Murata, Yuko Minami, et al.
Clinical and Vaccine Immunology : CVI|February 19, 2010
Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Ann R Falsey, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinics in Laboratory Medicine|November 7, 2009
Respiratory syncytial virus vaccine developmentYoshihiko Murata
Current Opinion in Pulmonary Medicine|April 23, 2008
Respiratory syncytial virus infection in adultsYoshihiko Murata
JMM Case Reports|July 1, 2017
Peripheral eosinophilia and eosinophilic colitis during long-term azole therapy for pulmonary aspergillosisBarbara Grzegorczyk, Yoshihiko Murata
Antiviral Therapy|October 20, 2007
Respiratory syncytial virus infection in adultsYoshihiko Murata, Ann R Falsey
Vaccine|June 26, 2012
Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in miceYoshihiko Murata, Seana C Catherman
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|December 18, 2021
Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocciSatoshi Iwata, Hayato Koyama, Yoshihiko Murata
The Journal of Infectious Diseases|March 3, 2007
Pulmonary complications of interpandemic influenza A in hospitalized adultsYoshihiko Murata, Edward E Walsh, Ann R Falsey
Archives of Internal Medicine|January 24, 2007
Impact of rapid diagnosis on management of adults hospitalized with influenzaAnn R Falsey, Yoshihiko Murata, Edward E Walsh
Cancer Science|November 20, 2020
ECT2 promotes lung adenocarcinoma progression through extracellular matrix dynamics and focal adhesion signalingZeinab Kosibaty, Yoshihiko Murata, Yuko Minami, et al.
Clinical and Vaccine Immunology : CVI|February 19, 2010
Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment proteinYoshihiko Murata, Paula M Lightfoote, Ann R Falsey, et al.
Pageof 5